Cargando…
Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics
Phase I dose‐finding trials in oncology seek to find the maximum tolerated dose of a drug under a specific schedule. Evaluating drug schedules aims at improving treatment safety while maintaining efficacy. However, while we can reasonably assume that toxicity increases with the dose for cytotoxic dr...
Autores principales: | Gerard, Emma, Zohar, Sarah, Thai, Hoai‐Thu, Lorenzato, Christelle, Riviere, Marie‐Karelle, Ursino, Moreno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292001/ https://www.ncbi.nlm.nih.gov/pubmed/33527351 http://dx.doi.org/10.1111/biom.13433 |
Ejemplares similares
-
Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens
por: Gerard, Emma, et al.
Publicado: (2021) -
Computational Aspects of N-Mixture Models
por: Dennis, Emily B, et al.
Publicado: (2015) -
Estimating Absolute and Relative Case Fatality Ratios from Infectious Disease Surveillance Data
por: Reich, Nicholas G., et al.
Publicado: (2012) -
Fair regression for health care spending
por: Zink, Anna, et al.
Publicado: (2020) -
The profile inter‐unit reliability
por: He, Kevin, et al.
Publicado: (2019)